Home > Drug Search >
  • company_query: Advantagene
  •   > 
Drug Filter
Category:
chemistry (24) biology (16)
Status:
Approved (2) NDA Filing (1) Phase Ⅲ (9) Phase Ⅱ (20) Phase Ⅰ (8)
Clinical Stage:
Pending (5) Active (23) Discontinued (10)
Bio-Type:
Gene therapy (3) Vaccine (10) Recombinant enzyme (1) Whole antibody (2)
Indication:
Asthma (2) Atopic dermatitis (1) Breast cancer (1) Community-acquired pneumonia (CAP) (1) Constipation (1) Duodenal ulcer (1) Dyslipidemia (2) Transplant rejection (1) Gastric ulcer (2) Pancreatitis (1) HBV infection (2) HIV infection (1) Influenza virus infection (2) Melanoma (1) Nausea and vomiting (1) Non-alcoholic fatty liver disease (NAFLD) (1) Obesity (1) Ovarian cancer (2) Overactive bladder (OAB) (3) Pancreatic cancer (1) Perennial allergic rhinitis (1) Prostate cancer (1) Respiratory tract infection (1) Seasonal allergic rhinitis (1) Solid tumours (1) Tinnitus (1) Exanthema (1) Tuberculosis (1) Type 2 diabetes (4) Ulcerative colitis (1) Urinary frequency (1) Urinary incontinence (1) Urinary urgency (1) Acute intermittent porphyria (1) Malignant pleural effusion (1) Otorhinolaryngological infection (1) Facial Erythema of Rosacea (1) Diabetes (1) Autoimmune diseases (1) Glioblastoma (1) Glioma (1) Allergic asthma (1) Thrombosis (2) Enterovirus infection (1) Alopecia (1) Mesothelioma (1) Interstitial cystitis (1) Celiac disease (1) Thromboembolism (1) Human papillomavirus infections (HPV) (1) Scleroderma (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top